HRP20181822T1 - Stabilizirani pripravci koji sadrže anti-interleukin-4 receptorska (il-4r) antitijela - Google Patents

Stabilizirani pripravci koji sadrže anti-interleukin-4 receptorska (il-4r) antitijela

Info

Publication number
HRP20181822T1
HRP20181822T1 HRP20181822TT HRP20181822T HRP20181822T1 HR P20181822 T1 HRP20181822 T1 HR P20181822T1 HR P20181822T T HRP20181822T T HR P20181822TT HR P20181822 T HRP20181822 T HR P20181822T HR P20181822 T1 HRP20181822 T1 HR P20181822T1
Authority
HR
Croatia
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
HRP20181822TT
Other languages
English (en)
Croatian (hr)
Inventor
Daniel B. Dix
Xiaolin Tang
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of HRP20181822T1 publication Critical patent/HRP20181822T1/hr

Links

HRP20181822TT 2010-10-06 2018-10-31 Stabilizirani pripravci koji sadrže anti-interleukin-4 receptorska (il-4r) antitijela HRP20181822T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
HRP20181822T1 true HRP20181822T1 (hr) 2018-12-28

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181822TT HRP20181822T1 (hr) 2010-10-06 2018-10-31 Stabilizirani pripravci koji sadrže anti-interleukin-4 receptorska (il-4r) antitijela

Country Status (13)

Country Link
AR (1) AR083338A1 (sr)
DK (2) DK2624865T3 (sr)
ES (2) ES2687813T3 (sr)
HK (1) HK1258305A1 (sr)
HR (1) HRP20181822T1 (sr)
HU (1) HUE052089T2 (sr)
LT (1) LT2624865T (sr)
PT (1) PT3354280T (sr)
RS (1) RS57850B1 (sr)
SI (1) SI2624865T1 (sr)
TW (7) TWI690329B (sr)
UA (1) UA111731C2 (sr)
UY (1) UY33652A (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR092177A1 (es) 2012-08-21 2015-03-25 Sanofi Sa Metodos para tratar o prevenir asma administrando un antagonista de il-4r
KR20230066127A (ko) * 2013-06-21 2023-05-12 사노피 바이오테크놀로지 Il-4r 길항제를 투여함에 의한 비용종증의 치료 방법
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
KR20170081262A (ko) 2014-11-14 2017-07-11 사노피 바이오테크놀로지 Il-4r 길항제의 투여에 의한, 비용종을 동반한 만성 부비동염의 치료 방법
KR20200081429A (ko) 2017-10-30 2020-07-07 사노피 바이오테크놀로지, 소시에떼 빠르 악씨옹 셍쁠리피에 Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
WO2010029664A1 (ja) * 2008-09-10 2010-03-18 日本エクスラン工業株式会社 架橋アクリレート系繊維およびその製造方法
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Also Published As

Publication number Publication date
DK3354280T3 (da) 2020-09-28
TW201716086A (zh) 2017-05-16
TWI718890B (zh) 2021-02-11
UA111731C2 (uk) 2016-06-10
TWI782325B (zh) 2022-11-01
DK2624865T3 (en) 2018-10-22
SI2624865T1 (sl) 2018-10-30
TWI568445B (zh) 2017-02-01
TW201542229A (zh) 2015-11-16
ES2687813T3 (es) 2018-10-29
TW201221141A (en) 2012-06-01
TW201924718A (zh) 2019-07-01
LT2624865T (lt) 2018-10-25
PT3354280T (pt) 2020-09-01
ES2820246T3 (es) 2021-04-20
UY33652A (es) 2012-04-30
RS57850B1 (sr) 2018-12-31
HUE052089T2 (hu) 2021-04-28
TWI690329B (zh) 2020-04-11
TWI498121B (zh) 2015-09-01
TW202320851A (zh) 2023-06-01
TW202102262A (zh) 2021-01-16
TW202026011A (zh) 2020-07-16
AR083338A1 (es) 2013-02-21
HK1258305A1 (zh) 2019-11-08
TWI679988B (zh) 2019-12-21

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations that include antibodies against the interleukin receptor (IL-4R)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501B (en) Stabilized liquid formulations containing antibody
HRP20170983T1 (hr) Pripravci s visokom koncentracijom antitijela
RS61082B1 (sr) Stabilno antitelo koje sadrži kompozicije
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS